Enterobacter spp.: Pathogens poised to flourish at the turn of the century

Clinical Microbiology Reviews

Volumn 10, Issue 2, 1997, Pages 220-241

  Eugene Sanders Jr , W Eugene ^a   Sanders, Christine C ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFALOTIN; CEFAMANDOLE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; TICARCILLIN;

ABDOMINAL INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTEREMIA; BACTERIAL ARTHRITIS; BACTERIAL ENDOCARDITIS; BACTERIAL INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; ENTEROBACTER; EYE INFECTION; LOWER RESPIRATORY TRACT INFECTION; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION; URINARY TRACT INFECTION;

BACTERIA (MICROORGANISMS); ENTEROBACTER; STAPHYLOCOCCI; STREPTOCOCCUS SP. 'GROUP A';

EID: 8244233838     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.10.2.220     Document Type: Review

References (246)

1. Al Ansari, N., E. B. McNamara, R. J. Cunney, M. A. Flynn, and E. G. Smyth. 1994. Experience with Enterobacter bactaeremia in a Dublin teaching hospital. J. Hosp. Infect. 27:69-72.
2. Alford, R. H., and A. Hall. 1987. Epidemiology of infections caused by gentamicin-resistant Enterobactcriaceae and Pseudomonas aeruginosa over 15 years at the Nashville Veterans Administration Medical Center. Rev. Infect. Dis. 9:1079-1086.
3. Almugeiren, M. M., and S. M. H. Qadri. 1991. Etiology of childhood urinary tract infections and antimicrobial susceptibility of uropathogens at a teaching hospital in Saudi Arabia. Curr. Ther. Res. 50:454-459.
4. Alvarez, C., K. Hunt, S. Ashley, and H. A. Reber. 1994. Emphysematous cholecystitis after ERCP. Dig. Dis. Sci. 39:1719-1723.
5. Andersen, B. M., S. M. Almdahl, D. Sorlie, R. Hotvedt, J. Backer-Christensen, R. B. Nlcolaysen, and O. I. Solem. 1990. Enterobacter chacae-infections at the University Hospital in Tromsa. Tidsskr. Nor. Laegeforen. 110:342-347. (In Norwegian.)
6. Anderson, E. L., and J. P. Hieber. 1983. An outbreak of gentamicin-resistant Enterobacter cloacae infections in a pediatric intensive care unit. Infect. Control 4:148-152.
7. Andresen, J., B. I. Asmar, and A. S. Dajani. 1994. Increasing Enterobacter bacteremia in pediatric patients. Pediatr. Infect. Dis. J. 13:787-792.
8. Arángiz, A. F., R. Alonso, K. Colom, A. Moria, E. Suinaga, and R. Cisterna. 1994. Multicenter study of cefotaxime resistance - 1993. Rev. Esp. Quimioterap. 7:57-61. (In Spanish.)
9. Armstrong, R. W., F. Bolding, and R. Joseph. 1992. Septic arthritis following arthroscopy: clinical syndromes and analysis of risk factors. Arthroscopy 8:213-223.
10. Aubert, G., P. P. Levy, A. Ros, R. Meley, B. Meley, A. Bourge, and G. Dorche. 1992. Changes in the sensitivity of urinary pathogens to quinolones between 1987 and 1990 in France. Eur. J. Clin. Microbiol. Infect. Dis. 11:475-477.
11. Ballow, C. H., and J. J. Schentag. 1992. Trends in antibiotic utilization and bacterial resistance. Report of the National Nosocomial Resistance Surveillance Group. Diagn. Micobiol. Infect. Dis. 15:37S-42S.
12. Bamberger, D. M., and S. L. Dahl. 1992. Impact of voluntary vs enforced compliance of third-generation cephalosporin use in a teaching hospital. Arch. Intern. Med. 152:554-557.
13. Baquero, F. 1995. Pneumococcal resistance to β-lactam antibiotics: a global geographic overview. Microb, Drug Resist. 1:115-120.
14. Barry, A. L., P. C. Fuchs, M. A. Pfaller, S. D. Allen, and E. H. Gerlach. 1990. Prevalence of fluoroquinolone-resistant bacterial isolates in four medical centers during the first quarter of 1990. Eur. J. Clin. Microbiol. Infect. Dis. 9:906-908.
15. Bauernfeind, A., R. Jungwirth, and S. Schweighart. 1989. In-vitro activity of meropenem imipenem, the penem HRE 664 and ceftazidime against clinical isolates from West Germany. J. Antimicrob. Chemother. 24(Suppl. A):73-84.
16. Bellon, J., and R. P. Mouton. 1992. Distribution of beta-lactamases in Enterobactcriaceae: Indoor versus outdoor strains. Chemotherapy 38:77-81.
17. Bennett, S. N., M. M. McNeil, L. A. Bland, M. J. Arduino, M. E. Villarino, D. M. Perrotta, D. R. Burwen, S. F. Welbel, D. A. Pegues, L. Stroud, P. S. Zeitz, and W. R. Jarvis. 1995. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N. Engl. J. Med. 333:147-154.
18. Bingen, E., E. Denamur, N. Lambert-Zechovsky, N. Brahimi, M. E. Lakany, and J. Elion. 1992. Rapid genotyping shows the absence of cross-contamination in Enterobacter cloacae nosocomial infections. J. Hosp. Infect. 21:95-101.
19. Bittner, M. J., D. L. Dworzack, L. C. Prehelm, R. W. Tofte, and K. B. Crossley. 1983. Ceftriaxone therapy of serious bacterial infections in adults. Antimicrob. Agents Chemother. 23:261-266.
20. Bodey, G. P., L. S. Elting, and S. Rodriguez. 1991. Bacteremia caused by Enterobacter. 15 years of experience in a cancer hospital. Rev. Infect. Dis. 13:550-558.
21. Bonadio, W. A., D. Margolis, and M. Tovar. 1991. Enterobacter cloacae bacteremia in children: a review of 30 cases in 12 years. Clin. Pediatr. 30:310-313.
22. Bone, R. C. 1993. Gram-negative sepsis: a dilemma of modern medicine. Clin. Microbiol. Rev. 6:57-68.
23. Bonfiglio, G., S. Stefani, and G. Nicoletti. 1994. In vitro activity of cefpirome against beta-lactamase-inducible and stably dcrepressed Enterobacteriaceae. Chemotherapy 40:311-316.
24. Bonten, M. J. M., C. A. Gaillard, F. H. van Tiel, H. G. W. Smeets, S. van der Geest, and E. E. Stobberingh. 1994. The stomach is not a source for colonization of the upper respiratory tract and pneumonia in ICU patients. Chest 105:878-883.
25. Bouza, E., M. G. de la Torre, E. L. A. Erice, J. M. Diaz-Borrego, and L. Buzón. 1985. Enterobacter bacteremia - an analysis of 50 episodes. Arch. Intern. Med. 145:1024-1027.
26. Breyer, S., S. M. Feistauer, H. Burgmann, M. Georgopoulos, and A. Georgopoulos. 1991. Epidemiology and spectrum of causative organisms of urinary tract infections. Themenheft Harnwegsinfekt. 23/24:533-536. (In German.)
27. Bruckner, D. A., and P. Colonna. 1995. Nomenclature for aerobic and facultative bacteria. Clin. Infect. Dis. 21:263-272.
28. Bryan, C. S., J. F. John, M. S. Pai, and T. L. Austin. 1985. Gentamicin vs cefotaxime for therapy of neonatal sepsis. Am. J. Dis. Child. 139:1086-1089.
29. Buchholz, D. H., V. M. Young, N. R. Friedman, J. A. Reilly, and J. M. R. Mardiney. 1971. Bacterial proliferation in platelet products stored at room temperature: transfusion-induced Enterobacter sepsis. N. Engl. J. Med. 285:429-433.
30. Burchard, K. W., D. T. Barrall, M. Reed, and G. J. Slotman. 1986. Enterobacter bacteremia in surgical patients. Surgery 100:857-861.
31. Burwen, D. R., S. N. Banerjee, R. P. Gaynes, and the N. N. I. S. System. 1994. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. J. Infect. Dis. 170:1622-1625.
32. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
33. Carsenti-Etesse, H., J. Durant, F. D. Salvador, M. Bensoussan, F. Bensoussan, C. Pradier, A. Thabaut, and P. Dellamonica. 1993. In vitro development of resistance of Streptococcus pneumoniae to β-lactam antibiotics. Microb. Drug Resist. 1:85-94.
34. Chamberland, S., J. L'Ecuyer, C. Lessard, M. Bernier, P. Provencher, M. G. Bergeron, and the C. S. Group. 1992. Antibiotic susceptibility profiles of 941 gram-negative bacteria isolated from septicemia patients throughout Canada. Clin. Infect. Dis. 15:615-628.
35. Chassagne, P., O. Mejjad, A. Daragon, R. Lecomte, X. LeLoet, and P. Deshayes. 1990. Spondylodiscitis due to Enterobacter cloacae treated with cefixime. Presse Med. 19:673-674. (In French.)
36. Chenoweth, C., and D. Schaberg. 1990. The epidemiology of enterococci. Eur. J. Clin. Microbiol. Infect. Dis. 9:80-89.
37. Chow, J. W., M. J. Fine, D. M. Shlaes, J. P. Quinn, D. C. Hooper, M. P. Johnson, R. Ramphal, M. M. Wagener, D. K. Miyashiro. and V. L. Yu. 1991. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann. Intern. Med. 115:585-590.
38. Chow, J. W., V. L. Yu, and D. M. Shlaes. 1994. Epidemiologic perspectives on Enterobacter for the infection control professional. Am. J. Infect. Control 22:195-201.
39. Chumbley, L. C. 1978. Canaliculitis caused by Enterobacter cloacae. Report of a case. Br. J. Ophthalmol. 68:364-366.
40. Chung, K. I., T. H. Lim, Y. S. Koh, J. H. Song, W. S. Kim, J. M. Choi, and Y. H. Auh. 1992. Nosocomial pneumonia in medico-surgical intensive care unit. J. Korean Med. Sci. 7:241-251.
41. Cohen, S. P., W. Yan, and S. B. Levy. 1993. A multidrug resistance regulatory chromosomal locus is widespread among enteric bacteria. J. Infect. Dis. 168:484-488.
42. Conus, P., and P. Francioli. 1992. Relationship between ceftriaxone use and resistance of Enterobacter species. J. Clin. Pharm. Ther. 17:303-305.
43. Daw, M. A., G. D. Corcoran, F. R. Falkiner, and C. T. Keane. 1992. Application and assessment of cloacin typing of Enterobacter cloacae. J. Hosp. Infect. 20:141-151.
44. deChamps, C., D. Guelon, D. Joyon, D. Sirot, M. Chanal, and J. Sirot. 1991. Treatment of meningitis due to an Enterobacter aerogenes producing a derepressed cephalosporinase and a Klebsiella pneumoniae producing an extended-spectrum β-lactamase. Infection 19:181-183.
45. deChamps, C., M. P. Sauvant, C. Chanal, D. Sirot, N. Gazuy, R. Malhuret, J. C. Baguet, and J. Sirot 1989. Prospective survey of colonization and infection caused by expanded spectrum-β-lactamase-producing members of the family Enterobacteriaceae in an intensive care unit. J. Antimicrob. Chemother. 27:2887-2890.
46. deChamps, C., D. Sirot, C. Chanal, M.-C. Poupart, M.-P. Dumas, and J. Sirot. 1991. Concomitant dissemination of three extended-spectrum β-lactamases among different Enterobacteriaceae isolated in a French hospital. J. Antimicrob. Chemother. 27:441-457.
47. Deguchi, K., N. Yokota, M. Koguchi, Y. Nakane, S. Fukayama, R. Ishihara, S. Oda, S. Tanaka, K. Sato, and T. Fukumoto. 1990. Antimicrobial activities of gentamicin against fresh clinical isolates. Jpn. J. Antibiot. 43:1674-1684. (In Japanese.)
48. de Oliviera, G. F., L. Barrucand, C. M. N. David, and P. P. G. Filho. 1990. The use of new generation beta-lactams und bacterial resistance in the Hospital Universitario da UFRJ. Folha Med. 101:237-242. (In Portuguese.)
49. Deusch, E., A. End, M. Grimm, W. Graninger, W. Kleptko, and E. Wolner. 1993. Early bacterial infections in lung transplant recipients. Chest 104:1412-1416.
50. Deutsch, D. H., S. F. Miller, and R. K. Finley. 1990. The use of intestinal antibiotics to delay or prevent infections in patients with burns. J. Burn Care Rehabil. 11:436-442.
51. Dornbusch, K., G. H. Miller, R. S. Hare, K. J. Shaw, and the E. S. Group. 1990. Resistance to aminoglycoside antibiotics in gram-negative bacilli and staphylococci isolated from blood. Reports from a European collaborative study. J. Antimicrob. Chemother. 26:131-144.
52. Edwards, J. R. 1995. Meropenem: a microbiological review. J. Antimicrob. Chemother. 36(Suppl. A):1-17.
53. Ehni, W. F., L. B. Reller, and I. R. T. Ellison. 1991. Bacteremia in ganulocytupenic patients in a tertiary-care general hospital. Rev. Infect. Dis. 13:613-619.
54. Ehrhardt, A. F., and C. C. Sanders. 1993. β-lactam resistance amongst Enifrobacter species. J. Antimicrob. Chemother. 32(Suppl. B):1-11.
55. Ehrhardt, A. F., C. C. Sanders, K. S. Thomson, C. Watanakunakorn, and I. Trujillano-Martin. 1993. Emergence of resistance to imipenem in Enterobacter isolates masquerading as Klebsiella pneumonias during therapy with imipenem/cilastatin. Clin. Infect. Dis. 17:120-122.
56. Eltahawy, A. T. A., A. A. Mokhtar, R. M. F. Khalaf, and A. A. Bahnassy. 1992. Postoperative wound infection at a university hospital in Jeddah, Saudi Arabia. J. Hosp. Infect. 21:79-83.
57. Falkiner, F. R. 1992. Enterobacter in hospital. J. Hosp. Infect. 20:137-140.
58. Farmer, J. J., III. 1995. Enterobacteriaccae: introduction and identification, p. 438-449. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
59. Farmer, J. J., III, M. A. Asbury, F. W. Hickman, D. J. Brenner, and the E. S. Group. 1980. Enterobacter sakazakii: a new species of "Enterobacteriaceae" isolated from clinical specimens. Int. J. Syst. Bactcriol. 30:569-584.
60. Farmer, J. J., III, B. R. Davis, F. W. Hickman-Brenner, A. McWhorter, G. P. Huntley-Carter, M. A. Asbuty, C. Riddle, H. G. Wathen-Grady, C. Elias, G. R. Fanning, A. G. Steigerwalt, C. M. O'Hara, G. K. Morris, P. B. Smith, and D. J. Brenner. 1985. Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens. J. Clin. Microbiol. 21:46-76.
61. Ferguson, R., C. Feeney, and V. A. Chirurgi. 1993. Enterobacter agglomerans-associated cotton fever. Arch. Intern. Med. 153:2381-2382.
62. Ferret, D., M. Bues-Charbit, C. Granthil, and G. Balansard. 1992. Pharmacoeconomic analysis of antibiotherapy in intensive care. J. Pharm. Clin. 11:177-182. (In French.)
63. Finegold, S. M., and C. C. Johnson. 1985. Lower respiratory tract infection. Am. J. Med. 79 (Suppl. 5B):73-77.
64. Flaherty, J. P., S. Garcia-Houchins, R. Chudy, and P. M. Arnow. 1993. An outbreak of gram-negative bacteremia traced to contaminated o-rings in reprocessed dialyzers. Ann. Intern. Med. 119:1072-1078.
65. Flynn, D. M., R. A. Weinstein, C. Nathan, M. A. Gaston, and S. A. Kabins. 1987. Patients' endogenous flora as the source of "nosocomial" Enterobacter in cardiac surgery. J. Infect. Dis. 156:363-368.
66. Fosgren, A., and M. Walder. 1994. Antimicrobial susceptibility of bacterial isolates in South Sweden including a 13-year follow-up study of some respiratory tract pathogens. APMIS 102:227-235.
67. Fryklund, B. A., K. Tullus, and L. G. Burman. 1994. Association between climate and Enterobacter colonization in Swedish neonatal units. Infect. Control Hosp. Epidemiol. 14:579-582.
68. Fuchs, P. C., A. L. Barry, and R. N. Jones. 1985. In vitro activity and disk susceptibility of timentin: current status. Am. J. Med. 79(Suppl. 5B):25-32.
69. Fuchs, P. C., R. N. Jones, A. L. Barry, and C. Thornsberry. 1985. Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin. Antimicrob. Agents Chemother. 27:679-682.
70. Fujimoto, T., and S. Mituhashi. 1992. In vitro antibacterial activity of levofloxacin, the (S)-( - )-ofloxacin. Chemotherapy (Japan) 40(Suppl.):1-13. (In Japanese.)
71. Fung, C.-P., L.-S. Wang, V.-C. Juang, G. Y. Liu, and D.-L. Cheng. 1988. Enterobacter cloacae bacteremia: clinical analysis of 41 cases. Clin. Med. J. (Taipei) 42:297-304.
72. Galili, D., A. Donitza, A. Garfunkel, and M. N. Sela. 1992. Gram-negative enteric bacteria in the oral cavity of leukemia patients. Oral Surg. Oral Med. Oral Pathol. 74:459-462.
73. Gallagher, P. G. 1990. Enterobacter bacteremia in pediatric patients. Rev. Infect. Dis. 12:808-812.
74. Gallagher, P. G., and W. S. Ball. 1991. Cerebral infarctions due to CNS infection with Enterobacter sakazakii. Pediatr. Radiol. 21:135-136.
75. Ganelin, R. S., and M. Ellis. 1992. Cellulitis caused by Enterobacter cloacae. J. Infect. 24:218-219. (Letter.)
76. García-Rodríguez, J. A., J. E. G. Sánchez, J. L. M. Bellido, and M. I. G. García. 1992. Current status of bacterial resistance to third-generation cephalosporins. Diagn. Microbiol. Infect. Dis. 15:67-72.
77. Gaston, M. A. 1988. Enterobacter: an emerging nosocomial pathogen. J. Hosp. Infect. 11:197-208.
78. Geerdes, H. F., D. Ziegler, H. Lode, M. Hund, A. Loehr, W. Fangmann, and J. Wagner. 1992. Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989. Clin. Infect. Dis. 15:991-1002.
79. George, R. C., L. C. Ball, and P. B. Norbury. 1990. Susceptibility to ciprofloxacin of nosocomial gram-negative bacteria and staphylococci isolated in the UK. J. Antimicrob. Chemother. 26(Suppl. F):145-156.
80. Georghiou, P. R., R. J. Hamill, C. E. Wright, J. Versalovic, T. Koeuth, D. A. Watson, and J. R. Lupski. 1995. Molecular epidemiology of infections due to Enterobacter aerogenes: identification of hospital outbreak-associated strains by molecular techniques. Clin. Infect. Dis. 20:84-94.
81. Gerding, D. N., T. A. Larson, R. A. Hughes, M. Weiler, C. Shanholtzer, and L. Peterson. 1991. Aminoglycoside resistance and aminoglycosidc usage: ten years of experience in one hospital. Antimicrob. Agents Chemother. 35:1284-1290.
82. Giamarellou, H., G. Koratzanis, K. Kanellakopoulou, and G. K. Daikos. 1985. Epidemiological study of Enterobacter cloacae resistant to 3rd generation cephalosporins: a preliminary report. Chemioterapia 4:43-46.
83. Goepp, J. G., C. K. K. Lee, T. Anderson, J. D. Dick, J. M. Stokoe, and J. Eiden. 1992. UK of ciprofloxacin in an infant with ventriculitis. J. Pediatr. 121:305-305.
84. Goldstein, F. W., Y. Péan, A. Rusato, J. Gertner, L. Gutmann, and the V. R. S. Group. 1993. Characterization of ceftriaxone-resistant Enterobacteriaceae: a multicentre study in 26 French hospitals. J. Antimicrob. Chemother. 32:595-603.
85. Greek Society for Microbiology. 1989. Antibiotic resistance among gram-negative bacilli in 19 Greek hospitals. J. Hosp. Infect. 14(12):177-181. (Letter.)
86. Greenberg, R. N., D. B. Bowne, M. Gelfand, and S. S. Sathe. 1990. Multicenter in vitro comparison of piperacillin and nine other antibacterials against 1,629 clinical isolates. Clin. Ther. 12:61-70.
87. Grier, J. F., S. W. Cohen, W. D. Grafton, and C. F. Gholson. 1994. Acute suppurative cholangitis associated with choledochal sludge. Am. J. Gastroenterol. 89:617-619.
88. Grüneberg, R. N. 1994. Changes in urinary pathogens and their antibiotic sensitivities, 1971-1992. J. Antimicrob. Chemother. 33(Suppl. A):1-8.
89. Gürses, N., and A. Oskan. 1988. Neonatal and childhood purpura fulminans: review of seven cases, CUTIS 41:361-363.
90. Haddy, R. I., M. L. Cecil, L. L. Norris, and R. J. Markert. 1991. Enterobacter bacteremia in the community hospital. J. Fam. Pract. 32:601-606.
91. Haertl, R., and G. Bandlow. 1993. Molecular typing of Enterobacter cloacae by pulsed-field gel electrophoresis of genomic restriction fragments. J. Hosp. Infect. 25:109-116.
92. Harabe, E., Y. Kawal, K. Kanazawa, M. Otsuki, and T. Nishino. 1992. In vitro and in vivo antibacterial activities of meropenem, a new carbapenem antibiotic. Drugs Exp. Clin. Res. 18:37-46.
93. Haug, J. B., S. Harthug, T. Kalager, A. Digrams, and C. O. Solberg. 1994. Bloodstream infections at a Norwegian university hospital, 1974-1979 and 1988-1969: changing etiology, clinical features and outcome. Clin. Infect. Dis. 19:246-256.
94. Hawkins, R. E., C. R. Lissner, and J. P. Sanford. 1991. Enterobacter sakasakii bacteremia in an adult. South. Med. J. 84:793-795.
95. Helovuo, H., K. Forssell, and K. Hakkarainen. 1991. Oral mucosal soft tissue necrosis caused by superinfection. Oral Surg. Oral Med. Oral Pathol. 71:543-548.
96. Helovuo, H., K. Hakkarainen, and K. Paurlo. 1993. Changes in the prevalence of subgingival enteric rods, staphylococcl and yeasts after treatment with penicillin and erythromycin. Oral Microbiol. Immunol. 8:75-79.
97. Hausser, M. F., J. E. Patterson, A. P. Kuritza, S. C. Edberg, and R. S. Baltimore. 1990. Emergence of resistance to multiple beta-lactams in Enterobacter cloacae during treatment for neonatal meningitis with cefotaxime. Pediatr. Infect. Dis. J. 9:509-512.
98. Hibbert-Rogers, L. C. F., J. Heritage, D. M. Gascoyne-Binzi, P. M. Hawkey, N. Todd, I. J. Lewis, and C. Bailey. 1995. Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward. J. Antimicrob. Chemother. 36:65-82.
99. Hoban, D. J., R. N. Jones, L. J. Harrell, M. Knudson, and D. Sewell. 1993. The North American component (the United States and Canada) of an international comparative MIC trial monitoring ofloxacin resistance. Diagn. Microbiol. Infect. Dis. 17:157-161.
100. Hopkins, J. M., and K. J. Towner. 1990. Enhanced resistance to cefotaxime and imlpenem associated with outer membrane protein alterations in Enterobacter aerogenes. J. Antimicrob. Chemother. 25:49-55.
101. Huovinen, S., M.-L. Klossner, M.-L. Katlla, and P. Huovinen. 1989. Plasmid-mediated beta-lactamases among aminoglycoside resistant gram-negative bacilli. Scand. J. Infect. Dis. 21:303-309.
102. Iannini, P. B., S. F. Hull, and R. Quintiliani. 1978. Severe sepsis from Enterobacter. Arch. Surg. 107:854-656.
103. Irvine, W. D., H. W. Flynn, D. Miller, and S. C. Pflugfelder. 1992. Endophthalmitis caused by Gram-negative organisms. Arch. Ophthalmol. 110:1450-1454.
104. Jacobson, K. L., S. H. Cohen, J. F. Inclardi, J. H. King, W. E. Lippert, T. Iglesias, and C. J. VanCouwenberghe. 1995. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group 1 β-lactamase-producing organisms. Clin. Infect. Dis. 21:1107-1113.
105. Jan Is, W. R., and W. J. Marione. 1992. Predominant pathogens in hospital infections. J. Antimicrob. Chemother. 29(Suppl. A):19-24.
106. Jarvis, W. R., J. W. White, V. P. Munn, J. L. Mosser, T. G. Emorl, D. H. Culver, C. Thornsberry, and J. M. Hughes. 1984. Nosocomial infection surveillance, 1983, p. 9SS-21SS. In CDC Surveillance Summaries, vol. 33 (no, 2SS). Centers for Disease Control, Atlanta, Ga.
107. John, J. F. J., R. J. Sharbaugh, and E. R. Bannister. 1982. Enterobacter cloacae: bacteremia, epidemiology, and antibiotic resistance. Rev. Infect. Dis, 4:13-28.
108. Johnson, M. P., and R. Kumphal. 1990. β-Lactam resistant Enterobacter bacteremia in febrile neutropenic patients receiving monotherapy. J. Infect. Dis. 162:981-983.
109. Jones, R. N. 1994. The antimicrobial activity of cefotaxime: comparative multinational hospital isolate surveys covering 15 years. Infection 22(Suppl. 3):S152-S160.
110. Jones, R. N. 1992. The current and future impact of antimicrobial resistance among nosocomial bacterial pathogens. Diagn. Microbiol. Infect. Dis. 15:3S-10S.
111. Jones, R. N. 1992. Fluoroquinolone resistance; an evolving national problem or just a problem for some physicians? Diagn. Microbiol. Infect. Dis. 15:177-179.
112. Jones, R. N., M. S. Barrett, and M. E. Erwin. 1994. In-vitro activity of FK-037, a new parenteral cephalosporin. J. Antimicrob. Chemother. 33:137-144.
113. Jones, R. N., A. L. Barry, and C. Thornsberry. 1989. In-vitro studies of meropenem. J. Antimicrob. Chemother. 24(Suppl. A):9-29.
114. Jones, R. N., M. E. Erwin, M. S. Barrett, D. M. Johnson, and B. M. Briggs. 1991. Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin, compared with other parenteral cephems. Diagn. Microbiol. Infect. Dis. 14:301-309.
115. Jones, R. N., M. A. Pfaller, P. C. Fuchs, K. Aldridge, S. D. Allen, and E. H. Gerlach. 1989. Piperacillin/Tazobactam (YTR 830) combination-comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strains. Diagn. Microbiol. Infect. Dis. 12:489-494.
116. Kappstein, I., G. Schulgen, T. Friedrich, P. Hellinger, A. Benzing, K. Geiger, and F. D. Daschner. 1991. Incidence of pneumonia in mechanically ventilated patients treated with sucralfate or cimetidine as prophylaxis for stress bleeding: bacterial colonization of the stomach. Am. J. Med. 91(Suppl. 2A):125S-131S.
117. Karnad, A., S. Alvarez, and S. L. Berk. 1987. Enterobacter pneumonia. South. Med. J. 80:601-604.
118. King, A., C. Boothman, and I. Phillips. 1990. Comparative in vitro activity of cefpirome and cefepime, two new cephalosporins. Eur. J. Clin. Microbiol. Infect. Dis. 9:677-685.
119. King, A., C. Boothman, and I. Phillips. 1989. Comparative in-vitro activity of meropenem on clinical isolates from the United Kingdom. J. Antimicrob. Chemother. 24(Suppl, A):31-45.
120. Kjolen, H., and B. M. Andersen. 1992. Handwashing and disinfection of heavily contaminated hands - effective or ineffective? J. Hosp. Infect. 21:61-71.
121. Kosakal, N., Y. Kumamoto, T. Hirose, N. Tanaka, Y. Hikichi, S. Shigeta, Y. Shiraiwi, H. Kameoka, H. Yoshida, M. Ogata, H. Tazaki, H. Iri, H. Uchida, Y. Kabayashi, S. Matsuda, R. Kitapwa, K. Fujita, Y. Hayashi, T. Oguri, T. Furusawa, Y. Takeuchi, H. Moriynma, and K. Shibata. 1992. Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1988). Jpn. J. Antibiot. 45:1236-1237. (In Japanese.)
122. Koumare, B., and F. Bougoudogo. 1993. Antibiotic resistance in 2187 strains isolated In Mali between 1980 and 1991. Med. Mal. Infect. 23:367-369. (Letter.) (In French.)
123. Kresken, M., A. Jansen, and B. Wiedeman. 1990. Prevalence of resistance of aerobic gram-negative bacilli to broad-spectrum antibacterial agents: results of a multicentre study. J. Antimicrob. Chemother. 25:1022-1024. (Letter.)
124. Kronish, J. W., and W. M. McLeish. 1991. Eyelid necrosis and periorbital necrosing fasclitis-report of a case and review of the literature. Ophthalmology 98:92-98.
125. Kühn, I., B. Ayling-Smith, K. Tullus, and L. G. Burman. 1993. The use of colonization rate and epidemic Index as tools to illustrate the epidemiology of faecal Enterobacteriaceae strains in Swedish neonatal wards. J. Hosp. Infect. 23:287-297.
126. Kühn, I., K. Tullus, and L. G. Burman. 1991. The use of the PhP-KE biochemical fingerprinting system in epidemiological studies of faecal Enterobacter cloacae strains from infants in Swedish neonatal wards. Epidemiol. Infect. 107:311-319.
127. Landry, P. P., W. Kamm, J. Bille, and J. P. Berger. 1991. Antibiotic susceptibility of bacteria isolated in the laboratory of a small hospital compared with those from a large hospital. Rev. Med. Suisse Romande 111:151-156. (In French.)
128. Lee, E.-H., E. Collatz, J. Trias, and L. Gutmann. 1992. Diffusion of β-lactam antibiotics into proteoliposomes reconstituted with outer membranes of isogenic imipenem-susceptible and -resistant strains of Enterobacter cloacae. J. Gen. Microbiol. 138:2347-2351.
129. Let, E.-H., M. H. Nicholas, M. D. Kitzkis, G. Pialou, E. Collate, and L. Gutmonn. 1991. Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem. Antimicrob. Agents Chemother. 35:1093-1098.
130. Legakis, N. J., and A. Tsakris. 1992. Antibiotic resistance mechanisms in gram-negative bacteria: the Greek experience. Int. J. Exp. Clin. Chemother. 5:83-91.
131. Leibovici, L., H. Konisberger, S. D. Pitlik, Z. Samra, and M. Drucker. 1992. Bacteremia and fungemia of unknown origin in adults. Clin. Infect. Dis. 14:436-443.
132. Leibovid, L., A. J. Wysenbeek, H. Konisberger, Z. Samra, S. D. Pitlik, and M. Drucker. 1992. Patterns of multiple resistance to antibiotics in gram-negative bacteria demonstrated by factor analysis. Eur. J. Clin. Microbiol. Infect. Dis. 11:782-788.
133. Lerner, A. M. 1980. The gram negative bacillary pneumonias. Dis. Mon. 27:1-56.
134. Leying, H., W. Cullmann, and W. Dick. 1991. Carbapenem resistance in Enterobacter aerogenes is due to lipopolysaccharide alterations. Chemotherapy 37:106-113.
135. Lindh, E., K. Dornbusch, K. Jalakas, and A. Forsgren. 1990. Antibiotic susceptibility and β-lactamase production in clinical isolates of Enterobacter spp. APMIS 98:462-470.
136. Lindh, E., P. Kjaeldgaard, W. Frederiksen, and J. Ursing. 1991. Phenotypical properties of Enterobacter agglomerans (Pantoea agglomerans) from human, animal and plant sources. APMIS 99:347-352.
137. Lindh, E., and J. Ursing. 1991. Genomic groups and biochemical profiles of clinical isolates of Enterobacter cloacae. APMIS 99:507-514.
138. Liu, P. Y. F., D. Gur, L. M. C. Hall, and D. M. Livermore. 1992. Survey of the prevalence of β-lactamases amongst 1000 gram-negative bacilli isolated consecutively at the Royal London Hospital. J. Antimicrob. Chemother. 30:429-447.
139. Livingston, W., M. E. Grossman, and G. Garvey. 1992. Hemorrhagic bullae in association with Enterobacter cloacae septicemia. J. Am. Acad. Dermatol. 27:637-638.
140. Loessner, M. J., E. Neugirg, R. Zink, and S. Scherer. 1993. Isolation, classification and molecular characterization of bacteriophages for Enterobacter species. J. Gen. Microbiol. 139:2627-2633.
141. Lovering, A. M., M. J. Bywater, H. A. Holt, H. M. Champion, and D. S. Reeves. 1988. Resistance of bacterial pathogens to four aminoglycosides and six other antibacterials and prevalence of aminoglycoside modifying enzymes, in 20 UK centres. J. Antimicrob. Chemother. 22:823-839.
142. Low, D. E., L. R. Kaiser, D. A. Haydock, E. Trulock, and J. D. Cooper. 1993. The donor lung: infectious and pathologic factors affecting outcome in lung transplantation. J. Thorac. Cardiovasc. Surg. 106:614-621.
143. Maes, P., and R. Vanhoof. 1992. A 56-month prospective surveillance study on the epidemiology of aminoglycoside resistance in a Belgian general hospital. Scand. J. Infect. Dis. 24:495-501.
144. Mani, S., S. C. Edberg, and J. E. Patterson. 1992. Community-acquired bacteremia due to multiresistant Enterobacter in a patient with urosepsis. Clin. Infect. Dis. 15:565-566.
145. Marce, S., J.-F. Antoine, T. Schaeverbeke, J.-P. Vernhes, B. Bannwarth, and J. Dehais. 1993. Enterobacter cloacae vertebral infection in a heroin addict with HIV infection. Ann. Rheum. Dis. 52:695. (Letter.)
146. Mascellino, M. T., E. Iona, S. Farinelli, F. Iegri, M. Marandola, M. L. Pennacchiotti, C. Cascioli, U. V. Comandini, and G. D. Logu. 1992. Plasmids as epidemiologic markers in nosocomial gram-negative bacilli: experience in an intensive care unit. Drugs Exp. Clin. Res. 18:121-128.
147. Massie, J. B., J. G. Heller, J.-J. Abitol, D. McPherson, and S. R. Garfin. 1992. Postoperative posterior spinal wound infections. Clin. Orthop. Relat. Res. 284:99-105.
148. Matsaniotis, N. S., V. P. Syriopoulou, M. C. Theodoridou, K. G. Tzanetou, and G. I. Mostrou. 1984. Enterobacter sepsis in infants and children due to contaminated intravenous fluids. Infect. Control 5:471-477.
149. Mayhall, C. G., V. A. Lamb, J. W. E. Gayle, and J. B. W. Haynes. 1979. Enterobacter cloacae septicemia in a burn center: epidemiology and control of an outbreak. J. Infect. Dis. 139:166-171.
150. McCabe, W. R., and G. G. Jackson. 1962. Gram-negative bacteremia. I. Etiology and ecology. Arch. Intern. Med. 110:847-855.
151. McConkey, S. J., D. C. Coleman, F. R. Falkiner, S. R. McCann, and P. A. Daly. 1989. Enterobacter cloacae in a haematology/oncology ward - first impressions. J. Hosp. Infect. 14:277-284.
152. McCown, R. B. 1988. Deep infection of the hand. Kansas Med. 89:189-190.
153. McGowan, J. E. 1985. Changing etiology of nosocomial bacteremia and fungemia und other hospital-acquired infections. Rev. Infect. Dis. 7(Suppl. 3):S357-S370.
154. Meis, J. F. G. M., J. Groot-Loonen, and J. A. A. Hoogkamp-Korstanje. 1995. A brain abscess due to multiply-resistant Enterobacter clocae success-fully treated with meropenem. C Clin. Infect. Dis. 20:1567. (Letter.)
155. Meyers, H. B., E. Fontanilla, and L. Mascolm. 1988. Risk factors for development of sepsis in a hospital outbreak of Enterobacter aerogenes. Am. J. Infect. Control. 16:118-122.
156. Milewski, S. A., and P. Klevjer-Anderson. 1993. Endophthalmitis caused by Enterobacter cloacae. Ann. Ophthalmol. 25:309-311.
157. Mirza, E. G., S. Karakücük, M. Doganay, and A. Caglayangil. 1994. Postoperative endophthalmitis caused by Enterobacter species. J. Hosp. Infect. 26:167-172.
158. Modi, N., V. Damjanovic, and R. W. I. Cooke. 1987. Outbreak of cephalosporin resistant Enterobacter cloacae infection in a neonatal intensive care unit. Arch. Dis. Child. 62:148-151.
159. Mulgrave, L. 1991. The changing ecology of hospital bacteria and the selective role of cephalosporins. Epidemiol. Infect. 106:121-132.
160. Murray, P. R., H. F. Cantrell, R. B. Lankford, and the I. V. S. S. Group. 1994. Multicenter evaluation of the in vitro activity of piperacillin-tazobac- tam compared with eleven selected β-lactam antibiotics and ciprofloxacin against more than 42,000 aerobic gram-positive and gram-negative bacteria. Diagn. Microbiol. Infect. Dis. 19:111-120.
161. Muytjens, H. L., and L. A. Kollée. 1990. Enterobacter sakazakii meningitis in neonates: causative role of formula? Pediatr. Infect. Dis. J. 9:372-373. (Letter.)
162. Muytjens, H. L., and J. van der Ros-van de Repe. 1986. Comparative in vitro susceptibilities of eight Enterobacter species, with special reference to Enterobacter sakazakii. Antimicrob. Agents Chemother. 29:367-370.
163. National Committee for Clinical Laboratory Standards. 1994. Performance standards for antimicrobial susceptibility testing. Fifth informational supplement. Dec. 1994. NCCLS document M100-S5. National Committee for Clinical Laboratory Standards, Villanova, Pa.
164. Nelson, J. D., and G. H. McCracken. 1989. Ceftazidime resistance in an ICU. Pediatr. Infect. Dis. Newsl. 15:10.
165. Neu, H. C., N.-X. Chin, K. Jules, and P. Labthavikul. 1986. The activity of BMY 28142, a new broad spectrum β-lactamase stable cephalosporin. J. Antimicrob. Chemother. 17:441-452.
166. Neu, H. C., N.-X. Chin, and A. Novelli. 1988. In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 32:1666-1675.
167. Ni Riain, U., M. G. Cormican, J. Flynn, T. Smith, and M. Glennon. 1994. PCR based fingerprinting of Enterobacter cloacae. J. Hosp. Infect. 27:237-240.
168. Nordmann, P., S. Mariotte, T. Naas, R. Labia, and M.-H. Nicolas. 1993. Biochemical properties of a carbapenem-hydrolyzing β-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrob. Agents Chemother. 37:939-946.
169. Noriega, F. R., K. L. Kotloff, M. A. Martin, and R. S. Schwalbe. 1990. Nosocomial bacteremia caused by Enterobacter sakazakii and Leuconostoc mesenteroides resulting from extrinsic contamination of infant formula. Pediatr. Infect. Dis. J. 9:447-449.
170. Palmer, D. L., J. N. Kuritsky, S. C. Lapham, R. M. King, and B. F. Aki. 1985. Enterobacter mediastinitis following cardiac surgery. Infect. Control 6:115-119.
171. Pareja, A., C. Bernal, A. Leyva, G. Piedrola, and M. C. Maroto. 1992. Etiologic study of patients with community-acquired pneumonia. Chest 101:1207-1210.
172. Pariente, D. 1993. Letter. Pediatr. Radiol. 23:331.
173. Pechere, J. C. 1991. Why are carbapenems active against Enterobacter cloacae resistant to third generation cephalosporins? Scand. J. Infect. Dis. 78(Suppl.):17-21.
174. Pena, C., M. Pujol, R. Pallares, M. Cisnal, J. Ariza, and F. Gudiol. 1993. Nosocomial bacteremia by Enterobacter spp.: epidemiology and prognostic factors. Enferm. Infect. Microbiol. Clin. 11:424-428. (In Spanish.)
175. Peyret, M., M. T. Albertini, M. Olleon, C. Davenas, and V. Blanc. 1993. Detection of the resistance phenotypes of Enterobacteriaceae to aminoglycosides with ATB plus expert system. Pathol. Biol. 41:329-336. (In French.)
176. Phillips, I., A. King, W. R. Gransden, and S. J. Eykyn. 1990. The antibiotic sensitivity of bacteria isolated from the blood of patients in St. Thomas' Hospital 1969-1988. J. Antimicrob. Chemother. 25(Suppl. C):59-80.
177. Piddock, L. J. V., and D. J. Griggs. 1991. Selection and characterization of cefepime-resistant gram-negative bacteria. J. Antimicrob. Chemother. 28:669-676.
178. Pitout, J. D. D., E. S. Moland, K. S. Thomson, C. C. Sanders, and S. R. Fitzsimmons. 1997. β-Lactamases and detection of β-lactam resistance in Enterobacter spp. Antimicrob. Agents Chemother. 41:35-39.
179. Pittet, D., D. Tarara, and R. P. Wenzel. 1994. Nosocomial bloodstream infection in critically ill patients. JAMA 271:1598-1601.
180. Prevot, M. H., A. Andremont, H. Sancho-Garnier, and C. Tancrede. 1986. Epidemiology of intestinal colonization by members of the family Enterobacteriaceae resistant to cefotaxime in a hematology-oncology unit. Antimicrob. Agents Chemother. 30:945-947.
181. Quinn, J. P., C. A. DiVincenzo, and J. Foster. 1987. Emergence of resistance to ceftazidime during therapy for Enterobacter cloacae infections. J. Infect. Dis. 155:942-947.
182. Rajan, R. K. 1982. Spontaneous bacterial peritonitis with ecthyma gangrenesum due to Escherichia coli. J. Clin. Gastroenterol. 4:145-148.
183. Redjeb, S. B., G. Fournier, A. Philippen, H. B. Yaghlane, R. Labia, and A. Boujnah. 1989. Prevalence of resistance phcnotypes to β-lactam antibiotics among 4800 isolates of Enterobacteriaceae and distribution of β-lactamases. Chemotherapia 8:336-338.
184. Rice, L. B., S. H. Willey, G. A. Papanicolaou, A. A. Medeiros, G. M. Eliopoulos, J. R. C. Moellering, and G. A. Jacoby. 1990. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic-care facility. Antimicrob. Agents Chemother. 34:2193-2199.
185. Rolston, K. V. I., M. E. Alvarez, K. C. Hsu, and G. P. Bodey. 1986. In-vitro activity of cefpirome (HR-810). WIN-49375, BMY-28142 and other antibiotics against nosocomially important isolates from cancer patients. J. Antimicrob. Chemother. 17:453-457.
186. Rubinstien, E. M., P. Klevjer-Anderson, C. A. Smith, M. T. Drouin, and J. E. Patterson. 1993. Enterobacter taylorae. a new opportunistic pathogen: report of four cases. J. Clin. Microbiol. 31:249-254.
187. Rubio, M. C., J. Gil. J. Castillo, I. Otal, M. L. Gómez-Lus, E. Rubio, C. Sarraseca, A. Torrellas, and R. Gómez-Lus. 1989. The susceptibility to amoxycillin/clavulanatc of Enterobacteriaceae with plasmid-mediated ampicillin resistance: a twelve-year study of strains in one Spanish hospital. J. Antimicrob. Chemother. 24(Suppl. B):35-40.
188. Rylander, R. 1987. The role of endotoxin for reactions after exposure to cotton dust. Am. J. Ind. Med. 12:687-697.
189. Rylander, R., and M. Ludholm. 1978. Bacterial contamination of cotton and cotton dust and effects on the lungs. Br. J. Ind. Med. 35:204-207.
190. Sanders, C. C. 1993. Cefepime: the next generation? Clin. Infect. Dis. 17:369-379.
191. Sanders, C. C. 1987. Chromosomal cephalosporinases responsible for multiple resistance to newer β-lactam antibiotics. Annu. Rev. Microbiol. 41:573-593.
192. Sanders, C. C. 1992. β-Lactamases of gram-negative bacteria: new challenges for new drugs. Clin. Infect. Dis. 14:1089-1099.
193. Sanders, C. C., and J. W. E. Sanders. 1992. β-lactam resistance in gram-negative bacteria: global trends and clinical impact. Clin. Infect. Dis. 15:824-839.
194. Schaberg, D. R., D. H. Culver, and R. P. Gaynes. 1991. Major trends in the microbial etiology of nosocomial infection. Am. J. Med. 91(Suppl. 3B):72S-75S.
195. Scheider, D. M., P. D. King, and B. W. Miedema. 1994. Ascites and secondary bacterial peritonitis associated with small bowel obstruction. Am. J. Gastroenterol. 89:1238-1240.
196. Schito, G. C., A. Sanna, C. Chezzi, G. Ravizzola, F. Leone, G. Molinari, M. G. Menozzi, and F. Pirali. 1989. In-vitro activity of meropenem against clinical isolates in a multicentre study in Italy. J. Antimicrob. Chemother. 24(Suppl. A):57-72.
197. Schonheyder, H. C., K. T. Jensen, and W. Frederiksen. 1994. Taxonomic notes. Synonymy of Enterobacter cancerogenus (Urosevic 1966) Dickey and Zumoff 1988 and Enterobacter taylorae Farmer et al. 1985 and resolution of an ambiguity in the biochemical profile. Int. J. Syst. Bacteriol. 44:586-587.
198. Scriver, S. R., C. A. R. S. Group, and D. E. Low. 1995. Comparative activity of several antimicrobial agents against nosocomial gram-negative rods isolated across Canada. Can. J. Infect. Dis. 6:76-82.
199. Shah, P. M., and W. Stille. 1992. Activity of meropenem and other antimicrobials against Enterobactcriaceac and Pseudomonas aeruginosa isolated in Frankfurt during 1989 and 1991. Spanish J. Chemother. 5(Suppl. 4):61-64.
200. Shanahan, P. M. A., B. A. Wylie, P. V. Adrian, H. J. Koornhof, C. J. Thomson, and S. G. B. Amyes. 1993. The prevalence of antimicrobial resistance in human faecal flora in South Africa. Epidemiol. Infect. 111:221-228.
201. Snydman, D. R. 1991. Clinical implications of multi-drug resistance in the intensive care unit. Scand. J. Infect. Dis. 22(Suppl. 78):54-63.
202. Solans, R., P. Simeon, R. Cuenca, V. Fonollosa, J. Bago, and M. Vilardell. 1992. Infectious discitis caused by Enterobacter cloacae. Ann. Rheum. Dis. 51:906-907.
203. Speciale, A., F. Caccamo, C. Cocuzza, and G. Nicoletti. 1990. Susceptibility of 1,787 nosocomial pathogens to ciprofloxacin and other antibiotics. Curr. Ther. Res. 47:226-238.
204. Spiliopoulou, L. A. Droukopoulou, A. Athanassladou, and G. Dimltracopoulos. 1992. Plasmid profiles of Acinetobacter and Enterobacter species of hospital origin: restriction endonuclease analysis of plasmid DNA and transformation of Escherichia coli by R plasmids. J. Chemother. 4:72-77.
205. Sramová, H., M. Daniel, V. Absolonová, D. Dedicova, Z. Jedlickova, H. Lhotova, P. Petras, and V. Subertova. 1992. Epidemiological role of arthropods detectable in health facilities. J. Hosp. Infect. 20:281-292.
206. Stefee, C. H., and B. L. Wasilauskas. 1992. Beta-lactamase expression and cross-resistance to beta-lactam antibiotics in a nosocomial population of Enterobacter. Chemotherapy 38:291-296.
207. Stenhouse, M. A. E. 1992. Enterobacter agglomerans as a contaminant of blood. Transfusion 32:86. (Letter.)
208. Struelens, M. J., F. Rost, A. Deplano, A. Maas, V. Schwam, E. Serruys, and M. Cremer. 1993. Pseudomonas aeruginosa and Enterubacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis. Am. J. Med. 95:489-498.
209. Tayor, G. D., T. Kirkland, J. La key, R. Rajotte, and G. L. Warnock. 1994. Bacteremia due to transplantation of contaminated cryopreserved pancreatic islets. Cell Transplant. 3:103-106.
210. Thomas, A., M. K. Lalitha, M. V. Jesudason, and S. John. 1993. Transducer related Enterobacter cloacae sepsis in post-operative cardiothoracic patients. J. Hosp. Infect. 25:211-214.
211. Thompson, B. D. 1975. Medical complications of heroin addiction. Ariz. Med. 32:798-801.
212. Thomson, K. S., W. E. Sanders, and C. C. Sanders. 1994. USA resistance patterns among UTI pathogens. J. Antimicrob. Chemother. 33(Suppl. A):9-15.
213. Thornsberry, C., S. D. Brown, Y. C. Yee, S. K. Bouchillon, J. K. Marier, and T. Rich. 1993. In-vitro activity of cefepime and other antimicrobials: survey of European isolates. J. Antimicrob. Chemother. 32(Suppl. B):31-53.
214. Toala, P., Y. H. Lee, C. Wilcox, and M. Finland. 1970. Susceptibility of Enterobacter aerogenes and Enterobacter cloacae to 19 antimicrobial agents in vitro. Am. J. Med. Sci. 260:41-55.
215. Toye, B. W., S. R. Scriver, D. E. Low, and the Canadian Antimicrobial Resistance Study Group. 1993. Canadian survey of antimicrobial resistance in Klebsiella spp. and Enterobacter spp. J. Antimicrob. Chemother. 32(Suppl. B):81-86.
216. Tsakris, A., A. P. Johnson, R. C. George, S. Mehtar, and A. C. Vatopoulos. 1991. Distribution and transferability of plasmids encoding trimethoprim resistance in urinary pathogens from Greece. J. Med. Microbiol. 34:153-157.
217. Tunkel, A. R., M. J. Fisch, A. Schlein, and W. M. Scheid. 1992. Enterobacter endocarditis. Scand. J. Infect. Dis. 24:233-240.
218. Twum-Danso, K., C. Grant, A. Al-Suleiman, S. Abdel-Khader, M. S. Al-Awami, H. Al-Breiki, S. Taha, A.-A. Ashoor, and L. Wosornu. 1992. Microbiology of postoperative wound infection: a prospective study of 1770 wounds. J. Hosp. Infect. 21:29-37.
219. Tzelepi, E., L. S. Tzouvelekis, A. C. Vatopoulos, A. F. Mentis, A. Tsakris, and N. J. Legakis. 1992. High prevalence of stably dercpressed class-1 β-lactamase expression in multiresistant clinical isolates of Enterobacter cloacae from Greek hospitals. J. Med. Microbiol. 37:91-95.
220. Tzouvelekis, L. S., E. Tzelepi, M. E. Kaufmann, and A. F. Mentis. 1994. Consecutive mutations leading to the emergence in vivo of imipenem resistance in a clinical strain of Enterobacter aerogenes. J. Med. Microbiol. 40:403-407.
221. Unhanand, M., M. M. Mustafa, G. H. McCracken, and J. D. Nelson. 1993. Gram-negative enteric bacillary meningitis: a twenty-one-year experience. J. Pediatr. 122:15-20.
222. Uzun, O., H. E. Akalin, M. Hayran, and S. Unal. 1992. Factors influencing prognosis in bacteremia due to gram-negative organisms: evaluation of 448 episodes in a Turkish university hospital. Clin. Infect. Dis. 15:866-873.
223. Varaldo, P. E., F. Biavasco, S. Mannelli, R. Pompei, and A Proietti. 1988. Distribution and antibiotic susceptibility of extraintestinal clinical isolates of Klebsiella, Enterobacter and Serratia species. Eur. J. Clin. Microbiol. Infect. Dis. 7:495-500.
224. Vázquez, F., M. C. Mendoza, M. H. Villar, F. Pérez, and F. J. Méndez. 1994. Survey of bacteremia in a Spanish hospital over a decade (1981-1990). J. Hosp. Infect. 26:111-121.
225. Verbist, L., for the International Study Group. 1993. Epidemiology and sensitivity of 8625 ICU and hematology/oncology bacterial isolates in Europe. Scand. J. Infect. Dis. 91(Suppl.):14-24.
226. Wade, J. J., N. Desai, and M. W. Casewell. 1991. Hygienic hand disinfection for the removal of epidemic vancomycin-resistant Enterococcus faecium and gentamicin-resistant Enterobacter cloacae. J. Hosp. Infect. 18:211-218.
227. Wagener, M. M., and V. L. Yu. 1992. Bacteremia in transplant recipients: a prospective study of demographics, etiologic agents, risk factors, and outcomes. Am. J. Infect. Control 20:239-247.
228. Wagner, S. J., L. I. Friedman, and R. Y. Dodd. 1994. Transfusion-associated bacterial sepsis. Clin. Microbiol. Rev. 7:290-302.
229. Wang, C.-C., M.-L. Chu, L.-J. Ho, and R.-C. Hwang. 1991. Analysis of plasmid pattern in paediatric intensive care unit outbreaks of nosocomial infection due to Enterobacter cloacae. J. Hosp. Infect. 19:33-40.
230. Wang, F., D.-M. Zhu, Y.-Q. Wang, and T. Ying. 1993. Fluoroquinolones in Shanghai: use and resistance. APUA Newsl. 11:1, 2, and 6.
231. Washington, J. A., II, C. C. Knapp, and C. C. Sanders. 1988. Accuracy of microdilution and the automicrobic system in detection of β-lactam resistance in gram-negative bacterial mutants with derepressed β-lactamase. Rev. Infect. Dis. 10:824-829.
232. Watanakunakorn, C., and J. Weber. 1989. Enterobacter bacteremia: a review of 58 episodes. Scand. J. Infect. Dis. 21:1-8.
233. Weber, D. A., and C. C. Sanders. 1990. Diverse potential of β-lactamase inhibitors to induce class 1 enzymes. Antimicrob. Agents Chemother. 34:156-158.
234. Weinstein, R. A. 1986. Endemic emergence of cephalosporin-resistant Enterobacter: relation to prior therapy. Infect. Control 7(Suppl.):120-123.
235. Weinstein, R. A. 1991. Epidemiology and control of nosocomial infections in adult intensive care units. Am. J. Med. 91(Suppl. 3B):179S-184S.
236. Welscher, M., and H. J. Kolmos. 1992. Retrospective 6-year study of Enterobacter bacteraemia in a Danish university hospital. J. Hosp. Infect. 20:15-24.
237. Weischer, M., and H. J. Kolmos. 1993. Ribotyping of selected isolates of Enterobacter cloacae and clinical data related to biotype, phage type, O-serotype. and ribotype. APMIS 101:879-886.
238. Weischer, M., H. J. Kolmos, M. E. Kaufmann, and V. T. Rosdahl. 1993. Biotyping. phage typing, and O-serotyping of clinical isolates of Enterobacter cloacae. APMIS 101:838-844.
239. Weischer, M., H. Schumacher, and H. J. Kolmos. 1994. Resistance characteristics of blood culture isolates of Enterobacter cloacae with special reference to beta-lactamases and relation to preceding antimicrobial therapy. APMIS 102:356-366.
240. Westbloom, T. U., and M. E. Coggins. 1987. Osteomyelitis caused by En- terobacter taylorae, formerly enteric group 19. J. Clin. Microbiol. 25:2432-2433.
241. Wiedemann, B., and M. Zühlsdorf. 1989. Antibacterial properties of meropenem towards clinical isolates, β-lactamase producers and laboratory mutants. J. Antimicrob. Chemother. 24(Suppl. A):197-205.
242. Willis, J., and J. E. Robinson. 1988. Enterobacter sakazakii meningitis in neonates. Pediatr. Infect. Dis. J. 7:196-199.
243. Wolff, M. A., C. L. Young, and R. Ramphal. 1993. Antibiotic therapy for Enterobacter meningitis: a retrospective review of 13 episodes and review of the literature. Clin. Infect. Dis. 16:772-777.
244. Wüst, J., R. Auckenthaler, C. Breer, R. Frei, I. Heinzer, and W. Kamm. 1994. Sensitivity to antibiotics of gram-negative bacteria in Swiss intensive care units. Schweiz. Med. Wochenschr. 124:1695-1700. (In German.)
245. Young, L. S. 1990. Gram-negative sepsis, p. 611-636. In G. L. Mandell, R. G. Douglas, Jr., and J. E. Bennett (ed.), Principles and practice of infectious diseases, 3rd ed. Churchill Livingstone. Inc., New York, N.Y.
246. Zervos, M. J., C. A. Kauffman, P. M. Therasse, A. G. Bergman, T. S. Mikesell, and D. R. Schaberg. 1987. Nosocomial infection by gentamicin-resistant Streptococcus fecalis: an epidemiologic study. Ann. Intern. Med. 106:687-691.